Minimally Invasive Hepatopancreatobiliary Surgery at a Large Regional Health System: Assessing the Safety of Program Expansion
The American Surgeon™ · 2024
DOI: 10.1177/00031348231192073 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2024. Verfasst von Samantha J Falls und 7 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Institute, Allegheny Health Network, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Liver, Hepatectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Complex, minimally invasive hepatopancreatobiliary surgery (MIS HPB) is safe at high-volume centers, yet outcomes during early implementation are unknown. We describe our experience during period of rapid growth in an MIS HPB program at a large regional health system.
Methods
During an increase in MIS HPB (60% greater from preceding year), hospital records of patients who underwent HPB surgery between 1/1/2019 and 12/31/2020 were reviewed. Operative time, estimated blood loss (EBL), conversion rates, length of stay (LOS), and perioperative outcomes were assessed.
Results
267 patients’ cases were reviewed. The population was 62 ± 13 years, 50% female, 90% white. MIS was more frequently performed for hepatic than pancreatic resections (59% vs 21%, P < .001). Open cases were more frequently performed for invasive malignancy in both pancreatic (70% vs 40%, P < .018) and hepatic (87% vs 70%, P = .046) resections. There was no difference in operative time between MIS and open surgery (293[218-355]min vs 296[199-399]min, P = .893). When compared to open, there was a shorter LOS (4[2-6]d vs 7[6-10]d, P < .001) and lower readmission rate (21% vs 37%, P = .005) following MIS. Estimated blood loss was lower in MIS liver resections, particularly when performed for benign disease (200[63-500]mL vs 600[200-1200]mL, P = .041). Overall 30-day mortality was similar between MIS and open surgery (1.0% vs 1.8%, P = 1.000).
Discussion
During a surgical expansion phase within our regional health system, MIS HPB offered improved perioperative outcomes when compared to open surgery. These data support the safety of implementation even during intervals of rapid programmatic growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surgical Institute, Allegheny Health Network, Pittsburgh, PA, USA.
- Drexel University College of Medicine, Philadelphia, PA, USA.
- Division of Surgical Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
Zitieren
APA
Falls, S. J., Maxwell, C. M., Kaye, D. J., Dighe, S. G., Schiffman, S. C., Bartlett, D. L., Wagner, P. L., & Allen, C. J. (2024). Minimally Invasive Hepatopancreatobiliary Surgery at a Large Regional Health System: Assessing the Safety of Program Expansion. The American Surgeon™. https://doi.org/10.1177/00031348231192073
Vancouver
Falls SJ, Maxwell CM, Kaye DJ, Dighe SG, Schiffman SC, Bartlett DL, et al. Minimally Invasive Hepatopancreatobiliary Surgery at a Large Regional Health System: Assessing the Safety of Program Expansion. The American Surgeon™. 2024. doi:10.1177/00031348231192073
BibTeX
@article{Falls2024,
author = {Falls, Samantha J and Maxwell, Conor M and Kaye, Dylan J and Dighe, Shruti G and Schiffman, Suzanne C and Bartlett, David L and Wagner, Patrick L and Allen, Casey J},
title = {Minimally Invasive Hepatopancreatobiliary Surgery at a Large Regional Health System: Assessing the Safety of Program Expansion},
journal = {The American Surgeon™},
year = {2024},
doi = {10.1177/00031348231192073}
}
EUVIMED